CALUMET INC (CLMT) Fundamental Analysis & Valuation

NASDAQ:CLMT • US1314281049

29.34 USD
-1.06 (-3.49%)
At close: Mar 9, 2026
29.34 USD
0 (0%)
After Hours: 3/9/2026, 4:10:55 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CLMT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CLMT. CLMT was compared to 207 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of CLMT have multiple concerns. CLMT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. CLMT Profitability Analysis

1.1 Basic Checks

  • In the past year CLMT has reported negative net income.
  • In the past year CLMT has reported a negative cash flow from operations.
  • CLMT had negative earnings in 4 of the past 5 years.
  • In the past 5 years CLMT reported 4 times negative operating cash flow.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.36%, CLMT is doing worse than 72.46% of the companies in the same industry.
  • CLMT's Return On Invested Capital of 5.73% is in line compared to the rest of the industry. CLMT outperforms 50.72% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CLMT is significantly below the industry average of 22.40%.
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROIC 5.73%
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.03%
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

  • CLMT's Operating Margin of 3.51% is on the low side compared to the rest of the industry. CLMT is outperformed by 67.15% of its industry peers.
  • CLMT's Operating Margin has declined in the last couple of years.
  • CLMT has a Gross Margin of 8.21%. This is in the lower half of the industry: CLMT underperforms 72.95% of its industry peers.
  • CLMT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.51%
PM (TTM) N/A
GM 8.21%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CLMT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLMT is destroying value.
  • CLMT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • CLMT has an Altman-Z score of 1.37. This is a bad value and indicates that CLMT is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.37, CLMT perfoms like the industry average, outperforming 49.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.37
ROIC/WACC0.67
WACC8.58%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.13 indicates that CLMT should not have too much problems paying its short term obligations.
  • CLMT has a Current ratio of 1.13. This is comparable to the rest of the industry: CLMT outperforms 49.76% of its industry peers.
  • A Quick Ratio of 0.62 indicates that CLMT may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.62, CLMT is not doing good in the industry: 71.01% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.62
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CLMT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 57.95% over the past year.
EPS 1Y (TTM)57.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.51%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.38%

3.2 Future

  • Based on estimates for the next years, CLMT will show a very strong growth in Earnings Per Share. The EPS will grow by 35.80% on average per year.
  • CLMT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.41% yearly.
EPS Next Y21.89%
EPS Next 2Y39.29%
EPS Next 3Y47.98%
EPS Next 5Y35.8%
Revenue Next Year2.03%
Revenue Next 2Y4.24%
Revenue Next 3Y7.71%
Revenue Next 5Y7.41%

3.3 Evolution

CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. CLMT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CLMT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLMT is valued a bit more expensive than 65.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.1
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • CLMT's earnings are expected to grow with 47.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.29%
EPS Next 3Y47.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLMT Dividend Analysis

5.1 Amount

  • CLMT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLMT Fundamentals: All Metrics, Ratios and Statistics

CALUMET INC

NASDAQ:CLMT (3/9/2026, 4:10:55 PM)

After market: 29.34 0 (0%)

29.34

-1.06 (-3.49%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-27
Earnings (Next)05-07
Inst Owners52.91%
Inst Owner Change-0.63%
Ins Owners2.93%
Ins Owner Change-0.16%
Market Cap2.55B
Revenue(TTM)N/A
Net Income(TTM)-37.20M
Analysts78.33
Price Target26.52 (-9.61%)
Short Float %10.29%
Short Ratio5.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)369.74%
Min EPS beat(2)-407.62%
Max EPS beat(2)1147.11%
EPS beat(4)2
Avg EPS beat(4)105.83%
Min EPS beat(4)-407.62%
Max EPS beat(4)1147.11%
EPS beat(8)4
Avg EPS beat(8)44.84%
EPS beat(12)6
Avg EPS beat(12)-404.2%
EPS beat(16)6
Avg EPS beat(16)-335.84%
Revenue beat(2)2
Avg Revenue beat(2)4.63%
Min Revenue beat(2)0.47%
Max Revenue beat(2)8.78%
Revenue beat(4)4
Avg Revenue beat(4)4.89%
Min Revenue beat(4)0.47%
Max Revenue beat(4)9.31%
Revenue beat(8)8
Avg Revenue beat(8)7.08%
Revenue beat(12)11
Avg Revenue beat(12)7.22%
Revenue beat(16)15
Avg Revenue beat(16)10.04%
PT rev (1m)38.67%
PT rev (3m)19.2%
EPS NQ rev (1m)7.25%
EPS NQ rev (3m)46.28%
EPS NY rev (1m)-12.5%
EPS NY rev (3m)38.64%
Revenue NQ rev (1m)5.27%
Revenue NQ rev (3m)4.25%
Revenue NY rev (1m)1.29%
Revenue NY rev (3m)1.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 17.1
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.87
Fwd EYN/A
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS46.65
BVpS-8.01
TBVpS-8.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROCE 7.26%
ROIC 5.73%
ROICexc 6.03%
ROICexgc 6.03%
OM 3.51%
PM (TTM) N/A
GM 8.21%
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.03%
ROIC(5y)N/A
ROICexc(3y)7.12%
ROICexc(5y)N/A
ROICexgc(3y)8.23%
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-44.77%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.65%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
F-Score4
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.38
Cap/Depr 43.36%
Cap/Sales 1.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.62
Altman-Z 1.37
F-Score4
WACC8.58%
ROIC/WACC0.67
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.51%
EPS Next Y21.89%
EPS Next 2Y39.29%
EPS Next 3Y47.98%
EPS Next 5Y35.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.38%
Revenue Next Year2.03%
Revenue Next 2Y4.24%
Revenue Next 3Y7.71%
Revenue Next 5Y7.41%
EBIT growth 1Y1018.9%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year3370.1%
EBIT Next 3Y276.55%
EBIT Next 5Y150.05%
FCF growth 1Y83.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.87%
OCF growth 3YN/A
OCF growth 5YN/A

CALUMET INC / CLMT FAQ

What is the ChartMill fundamental rating of CALUMET INC (CLMT) stock?

ChartMill assigns a fundamental rating of 1 / 10 to CLMT.


What is the valuation status for CLMT stock?

ChartMill assigns a valuation rating of 1 / 10 to CALUMET INC (CLMT). This can be considered as Overvalued.


Can you provide the profitability details for CALUMET INC?

CALUMET INC (CLMT) has a profitability rating of 0 / 10.


What is the earnings growth outlook for CALUMET INC?

The Earnings per Share (EPS) of CALUMET INC (CLMT) is expected to grow by 21.89% in the next year.


Is the dividend of CALUMET INC sustainable?

The dividend rating of CALUMET INC (CLMT) is 0 / 10 and the dividend payout ratio is 0%.